MACRO-I for Cardiovascular Disease
(MACRO Trial)

Recruiting in Palo Alto (17 mi)

+2 other locations

Overseen byDaniel E Forman

Age: 65+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: University of Pittsburgh

No Placebo Group

Trial Summary

What is the purpose of this trial?

Modified Application of Cardiac Rehabilitation for Older Adults (MACRO) responds to a critical underuse of cardiac rehabilitation in older adults with a coaching model that addresses issues related to aging as a means to better facilitate cardiac rehabilitation (CR). MACRO is a randomized controlled trial (RCT) in which older adults with a CVD event are randomized between a MACRO intervention (MACRO-I) versus usual care. The MACRO-I is designed to facilitate CR as a means to augment functional recovery.

Research Team

Daniel E Forman

Principal Investigator

University of Pittsburgh

Eligibility Criteria

This trial is for older adults aged 70 or above who have had a cardiovascular disease event and can participate in the study's activities. They must speak English and be able to give informed consent. People with non-CVD conditions expected to be fatal within a year, severe cognitive impairment, or those unable to follow up by phone or in person are excluded.

Inclusion Criteria

I am 70 years old or older.

I have been hospitalized or treated for a serious heart condition.

I speak English.

See 2 more

Exclusion Criteria

I do not have severe cognitive impairment.

I do not have a non-heart related condition expected to be fatal within a year.

My health is stable without any recent serious issues.

See 2 more

Treatment Details

Interventions

MACRO (Behavioral Intervention)
MACRO-I (Behavioral Intervention)
Standard of Care (Other)
Usual Care (Other)

Trial OverviewThe MACRO trial tests a new coaching model called MACRO-I against usual care for cardiac rehabilitation (CR) in older adults. It aims to improve CR use and functional recovery after CVD events by addressing aging-related issues through random assignment of participants.

Participant Groups

2Treatment groups

Experimental Treatment

Active Control

Group I: MACRO-IExperimental Treatment1 Intervention

A coaching intervention that supplements usual care.

Group II: Usual CareActive Control1 Intervention

Care after an acute heart event will be at the discretion of the participants' clinical providers.